Filing Details
- Accession Number:
- 0001562180-24-004665
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-04 18:05:58
- Reporting Period:
- 2024-05-31
- Accepted Time:
- 2024-06-04 18:05:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1831363 | Terns Pharmaceuticals Inc. | TERN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1775429 | J. Mark Vignola | C/O Terns Pharmaceuticals, Inc. 1065 East Hillsdale Blvd., Suite 100 Foster City CA 94404 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-05-31 | 4,791 | $4.44 | 91,940 | No | 5 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | P | Direct |
Footnotes
- Includes the purchase of 4,791 shares under the Terns Employee Stock Purchase Plan on May 31, 2024.
Billionaire Hedge Funds
